insights_auto
Why is CSBR down 3.30%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
$ 4.44
arrow_downward
-3.30%(-0.15) 1D
11-р сарын 18, 16:00:00 (GMT-5) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$ 4.55
High
$ 4.60
Low
$ 4.41
Mkt. cap
61.82 сая
Avg. vol.
7.41 мян
Volume
0.00
52-wk high
$ 8.31
52-wk low
$ 4.41
EPS
-$ 0.08
Beta
0.47
Shares outstanding
13.92 сая
No. of employees
217
Open
$ 4.55
High
$ 4.60
Low
$ 4.41
Mkt. cap
61.82 сая
Avg. vol.
7.41 мян
Volume
0.00
52-wk high
$ 8.31
52-wk low
$ 4.41
EPS
-$ 0.08
Beta
0.47
Shares outstanding
13.92 сая
No. of employees
217
News stories
From web sources and news partners
EBC Financial Group
·
21 цагийн өмнө
Монголоос S&P 500 индексээр хэрхэн арилжаа хийх вэ: SPXUSD гарын авлага 2026
БКС Экспресс
·
3 цагийн өмнө
О сильных трендах в S&P 500, Brent, Gold, NG и TTF
ProFinance
·
15 цагийн өмнө
UBS ждёт S&P 500 на 8200 пунктах, но снижает оценку привлекательности акций
Oninvest
·
17 цагийн өмнө
Только двум акциям Mag7 удалось обогнать S&P 500 с начала 2025-го. Стоит ли их купить
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, Нью Жерси, Америкийн Нэгдсэн Улс
SectorHealth Care
Industry-
Websitechampionsoncology.com